Pediatric Sedation in the Emergency Department: Trends from a Nationwide Population-based Study in Korea, 2007-2018

Jeong Yong Lee1, Seung Jun Choi1, Jun Sung Park1

  • 1Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

Pediatric emergency department (ED) sedation in Korea shows changing trends. Ketamine use increased significantly, becoming the most common sedative, while chloral hydrate use decreased.

Area of Science:

  • Emergency Medicine
  • Pediatric Sedation
  • Health Services Research

Background:

  • Pediatric sedation in emergency departments (EDs) is common in Korea.
  • Understanding trends in pediatric sedation is crucial for improving care.

Purpose of the Study:

  • To investigate patient characteristics and sedative use in Korean EDs.
  • To analyze changes in pediatric sedation trends over time.

Main Methods:

  • Nationwide population-based retrospective study (2007-2018).
  • Utilized Korean Health Insurance Review and Assessment Service database.
  • Analyzed pediatric patients (≤15 years) receiving sedation in EDs.

Main Results:

  • Over 468,000 sedation visits recorded.
  • Most sedations (71.0%) were for children aged 1-3 years, primarily for injury diagnosis (93.5%).
  • Significant shift from chloral hydrate (70.6% to 28.6%) to ketamine (23.8% to 60.7%) use; ketamine became dominant by 2014.
  • Age-specific sedative preferences observed: chloral hydrate (<1, 1-3 yrs), ketamine (4-10 yrs), midazolam (11-15 yrs).

Conclusions:

  • Patient characteristics and sedative preferences in pediatric ED sedation have evolved.
  • These trends necessitate consideration for future Korean guidelines on pediatric ED sedation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
346